Preview
Blood component therapy can be lifesaving and, on occasion, life-threatening. To maximize the former and minimize the latter, physicians need to know the latest information on indications and complications. Drs Tarnower and Clark discuss recommendations on when and when not to transfuse red blood cells, platelets, and fresh frozen plasma. They also explain how to deal with two major transfusion-related complications: alloimmunization and graft-versus-host disease.